
Adapted from a human eczema survey, the 0-to-30 scale proved consistent and responsive to change, though it fell short on ear disease.
Thomas P. Lewis II, DVM, DACVD, discusses the possible concerns of this drug combination on the liver.
Thomas P. Lewis II, DVM, DACVD, discusses the concerns about the possible effects of this drug combination on the liver.


